Conversion from twice-to once-daily extended-release theophylline treatment in patients with reversible airway obstruction

Robert B. Berkowitz, David G. Tinkelman, J. Paul Marcoux, Anthony R. Rooklin, Howard J. Zeitz, Stephen I. Rennard, Burton A. Moss, Richard C. Hubbard, Richard R. Lorber

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Conversion from twice-to once-daily extended-release theophylline treatment in patients with reversible airway obstruction'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Keyphrases

Nursing and Health Professions